Colin Broom Md.

VP & Chief Scientific Officer, ViroPharma.

Companies

Nabriva Therapeutics plcBoard member Sep 26, 2017 to Aug 4, 2022¹
Nabriva Therapeutics plcChief executive officer Dec 30, 2016 to Jun 25, 2018²
NPS Pharmaceuticals (United States)Board member Jul 13, 2009 to Feb 24, 2015³
ViroPharmaVP & Chief Scientific Officer Jan 19, 2006 to Jan 28, 2014⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Nabriva Therapeutics plc36,523 shares⁵Aug 2, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 2, 2022Sold 5,339 shares at $0.19 of Nabriva Therapeutics plc⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNabriva Therapeutics plc, Board member
2
SEC EDGARNabriva Therapeutics plc, Chief executive officer
3
SEC EDGARNPS Pharmaceuticals (United States), Board member
4
SEC EDGARViroPharma, VP & Chief Scientific Officer
5
SEC EDGARNabriva Therapeutics plc shares after the filing of Aug 2, 2022